Xiang-peng Kong

Title: Innovations and Contributions of Inventor Xiang-peng Kong

Introduction

Xiang-peng Kong is a notable inventor based in New York, NY, who has made significant contributions to the field of immunology. He holds three patents that focus on innovative approaches to developing immunogenic polypeptides aimed at combating HIV-1.

Latest Patents

One of his latest patents is titled "Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide." This invention involves a recombinant immunogenic polypeptide that includes a loop peptide inserted into an immunogenic scaffold protein. The loop polypeptide presents specific epitopes of the HIV gp120 protein, inducing an antibody response that neutralizes various HIV-1 viruses. Another significant patent is "Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies." This patent describes the insertion of HIV-1 V3 loop peptides into selected immunogenic scaffold proteins, resulting in a potent V3 immunogen that can induce broadly reactive anti-gp120 antibodies.

Career Highlights

Xiang-peng Kong has worked at prestigious institutions such as New York University and the University of Massachusetts. His work has focused on developing innovative solutions to enhance immune responses against HIV-1, showcasing his dedication to advancing medical science.

Collaborations

He has collaborated with notable colleagues, including Timothy J Cardozo and Susan Zolla-Pazner, contributing to a rich exchange of ideas and research in the field of immunology.

Conclusion

Xiang-peng Kong's innovative work in developing immunogenic polypeptides represents a significant advancement in the fight against HIV-1. His contributions continue to inspire further research and development in immunology.